New Topical Drug Made from Spider Venom Shows Promise for Treating Erectile Dysfunction
A groundbreaking new drug for erectile dysfunction (ED) has emerged from an unexpected source – the venom of the Brazilian wandering spider. A Brazilian-based pharmaceutical company has successfully developed a topical gel made from this spider’s venom, which has shown promising results in its early human trials.
The Brazilian wandering spider, also known as the banana spider, is infamous for its bite, which can lead to elevated heart rate, shock, convulsions, and even death. One curious side effect of the spider’s venom is that it causes prolonged erections, known as priapism. This unique characteristic has intrigued scientists for years, leading them to explore its potential in treating ED.
Researchers at the Federal University of Minas Gerais in Brazil have delved into the mechanisms underlying the spider venom’s effects and have found a way to harness its power for the benefit of men suffering from ED. The first phase of human clinical trials for the topical gel has yielded positive results, assuaging concerns about its potential risks.
The topical gel, when applied in minimal amounts, has shown the ability to increase blood flow to the penis by elevating the level of nitric oxide, a crucial molecule for achieving erections. Importantly, the gel does not reach toxic levels in the bloodstream. Topical treatments like this have fewer side effects compared to traditional ED pills, making them an attractive option for many patients.
Further testing of the spider venom ED drug is set to commence soon. This next phase will involve a larger-scale study, focusing on patients who have undergone prostate removal, a procedure that can damage the nerves responsible for maintaining erections. A total of 72 individuals will participate in the study, divided into three groups to assess the drug’s effectiveness compared to alternative treatment options.
The development of this spider venom-based topical gel marks a significant advancement in the field of ED treatment. If successful, it could offer a novel and potentially safer option for those experiencing difficulties in achieving and maintaining erections. As the drug progresses through further testing, researchers hope to bring it closer to becoming a viable and effective treatment for ED.
– Gizmodo: [insert link]
– Image Source: Ivan Kuzmin / Adobe